中来股份 reported revenue of ¥1.17B for the period ended 2026-06-30, -64.7% year on year. Net income was ¥-0.35B, a -29.9% net margin on a 4.3% gross margin. The largest revenue line is 光伏组件 at 61% of the total. Free cash flow for the period was ¥0.31B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.17B | -64.7% |
| Gross profit | ¥0.05B | — |
| Operating income | ¥-0.44B | — |
| Net income | ¥-0.35B | — |
| Gross margin | 4.3% | Net margin -29.9% |
| Revenue Q/Q | +35.6% | — |
| Segment | Revenue | Share |
|---|---|---|
| 光伏组件 | ¥0.71B | 61.0% |
| 光伏辅材 | ¥0.27B | 22.9% |
| 光伏发电及运维 | ¥0.13B | 11.3% |
| 光伏电池 | ¥0.04B | 3.2% |
| 光伏应用 | ¥0.01B | 0.8% |
| 其他 | ¥0.01B | 0.8% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥1.12B | 95.7% |
| R&D | ¥0.10B | 8.6% |
| SG&A | ¥0.17B | 14.7% |
| Tax & other | ¥-0.09B | -7.6% |
| Item | Amount |
|---|---|
| Total assets | ¥13.17B |
| Total liabilities | ¥10.91B |
| Shareholders' equity | ¥2.26B |
| Equity / assets | 17.2% |
| Operating cash flow | ¥0.40B |
| Capital expenditure | ¥0.08B |
| Free cash flow | ¥0.31B |
| Cash conversion (OCF / net income) | -109% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
菲利华 ・ ST迪瑞 ・ 天和防务 ・ 飞凯材料 ・ 天利科技 ・ 劲拓股份 ・ 花园生物 ・ 宝色股份 ・ 汉宇集团 ・ 博济医药 ・ 科隆股份 ・ 九强生物
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies